Avra Medical Robotics
A New Era in Surgical Robotics

Human life expectancy has been increasing at a rapid rate, and treatment demands have become far more complex than years ago. The Association of American Medical Colleges predicts a shortfall of 100,000 physicians by 2030. With better healthcare regimes, increased hygiene, healthier lifestyles, and improved medical care, it was only a matter of time that forward-looking technology like robotics made its entry into the medical field.

AVRA Medical Robotics (AVRA), a surgical digital technology company, has realized the hidden potential of surgical robotics systems in terms of improved accuracy, navigation, targeting, imaging, and visualization, which would open the gates into all aspects of surgical care. The AVRA medical team was one of the earliest adopters of performing robotically assisted, minimally-invasive surgeries. AVRA’s surgeons have joined forces with engineers and scientists to design and develop a novel, computer-integrated, semi/ autonomous robotic platform that is truly disruptive. The company is revolutionizing the practice of medicine by innovating a fully autonomous robotic system that ‘robotizes’ a vast range of medical procedures presently being performed by human hands using surgical and non-surgical tools and devices.

Poised to usher in a modern era of surgery infused with robotics, AVRA is currently working on a unique surgical robotic platform in the field of aesthetic medicine. They are designing a proprietary intelligent AVRA Instrument Guidance System (AIGS) to help surgeons simulate procedures for preoperative review prior to performing surgery. The AIGS’ patient-specific mapping will be able to optimize results both for the surgeon and the patient.

With human-machine interactions incorporated into AVRA’s advanced technology, the company is set to redefine the term ‘robotic’ by enabling autonomy in surgical robots.AVRA’s imaging technology will be able to provide high-resolution, multi-dimensional imagery with technology-incorporated scanning and registration. Using AVRA’s imaging and instrument guidance technology, the surgical field will be able to carry out unprecedented minimally invasive treatment with significant precision and accuracy.

Furthermore, to reduce or even eliminate the key factors to patient anxiety, AVRA is employing its technology to devise tactics of precisely improving biopsy result waiting times from days or weeks to mere minutes.

The primary goal for AVRA is to enable surgeons to achieve consistently excellent results for the patient. Through the use of advanced technology, AVRA’s intelligent robotic platform will combine attributes of imaging with target acquisition and guidance to navigate with unprecedented accuracy and precision. Honing in on their knowledge of biological neural networks, AVRA is focused on incorporating artificial intelligence for superior diagnostic and therapeutic capabilities. These advanced, semi/autonomous systems will have boundless diagnostic and therapeutic applications to target, diagnose, and treat. AVRA is combining their research and development efforts to meet the increasing demands of both patients and practitioners for the efficiency, precision, and safety offered by robotics and artificial intelligence.



Apart from aesthetic medicine, AVRA is developing their platform-independent design to be flexible, which will allow the platform to be applicable in a diverse range of medical disciplines. The second phase that AVRA will be covering after aesthetics will be internal organ targeting, which will involve procedures including mapping, biopsy, and tissue targeting. When and where there arises the need for operations in soft tissue, neuro, and spine surgery, AVRA will be there to meet it.